In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
395 News Items found
Medical oncologist Alexander Drilon
In the Clinic
A Perfect Match: Molecular Tests Developed at MSK Guide Personalized Treatment for Lung Cancer

For personalized treatment to work, it’s important to analyze each person’s tumor for genetic mutations and find the best drugs to target those mutations.
Patient receiving stereotactic body radiation therapy at Memorial Sloan Kettering Cancer Center.
Ablative Radiotherapy Controls Resistant Non-Small Cell Lung Cancer in Clinical Trial

Learn how highly focused, intense radiation can stop lung cancer from growing after it has spread to a small number of sites.
MSK pathologist Natasha Rekhtman and physician-scientist Charles Rudin
MSK Scientists Identify Rare (Rb-Proficient) Subtype of Small Cell Lung Cancer

Unlike most small cell lung cancer tumors, these retain a normal copy of a protein called RB.
A close up of a microscope with two people wearing white coats in the background
ESMO 2025: MSK Presents New Research, Including Latest on Lung and Pancreatic Cancer Treatments

MSK highlights from the recent European Society for Medical Oncology (ESMO) Congress include promising findings on new lung, pancreatic, and colorectal cancer treatments and new insights for how molecular testing can guide personalized medicine.
A sign welcomes attendees to the AACR meeting in New Orleans.
Roundup
MSK’s Research Roundup at AACR 2022: Targeted Therapy for Lung Cancer, Using Statins With a Breast Cancer Drug, and Diagnosing Blood Cancer

MSK studies presented at the 2022 American Association for Cancer Research meeting include updates on a targeted therapy for lung cancer, lab research on combining statins with a breast cancer drug, and a new tool for diagnosing blood cancer.
Large letters that say ASCO promoting annual meeting in Chicago.
MSK Researchers Present Advances in Lung Cancer Treatment at 2024 ASCO Meeting

Read about advances in lung cancer treatment presented by MSK scientists at the 2024 ASCO meeting.
MSK's Wungki Park, MD, seen smiling in laboratory.
First-in-Class Investigational Drug KRAS G12D Degrader Shows Promise in Lung and Pancreatic Cancers

Learn how a novel drug is showing promise against lung and pancreatic cancer in early clinical trials by targeting the KRAS G12D mutation with a KRAS degrader.
Ingrid Adams speaks with nurse practitioner Virginia Ferreira.
In the Clinic
FDA Approves New Drug for Non-Small Cell Lung Cancer With ROS1 Fusions

Learn more about the new FDA-approved drug repotrectinib (AugtyroTM), which targets ROS1 fusions in lung cancer and other cancer types.
Memorial Sloan Kettering thoracic surgeon Prasad Adusumilli
New Finding Could Predict Which People with Lung Cancer Will Benefit from Chemotherapy

Researchers identify a biomarker that could predict which lung cancer patients will respond to chemotherapy.
Doctor and patient looking at x-ray of lungs.
In the Clinic
Older Age Is Not a Limiting Factor for Lung Cancer Surgery

Learn why surgery is still a good option for older patients with early-stage lung cancer.